Lourd Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | $1.42M | Buy |
34,593
+1,033
| +3% | +$42.5K | 0.13% | 29 |
|
2019
Q1 | $1.35M | Sell |
33,560
-34,918
| -51% | -$1.41M | 0.13% | 26 |
|
2018
Q4 | $2.84M | Buy |
68,478
+946
| +1% | +$39.2K | 0.22% | 23 |
|
2018
Q3 | $2.82M | Buy |
67,532
+4,195
| +7% | +$175K | 0.18% | 23 |
|
2018
Q2 | $2.18M | Sell |
63,337
-597
| -0.9% | -$20.5K | 0.31% | 28 |
|
2018
Q1 | $2.15M | Buy |
63,934
+204
| +0.3% | +$6.87K | 0.29% | 32 |
|
2017
Q4 | $2.19M | Buy |
63,730
+33,615
| +112% | +$1.16M | 0.14% | 33 |
|
2017
Q3 | $1.02M | Sell |
30,115
-1,919
| -6% | -$65K | 0.09% | 37 |
|
2017
Q2 | $1.02M | Buy |
32,034
+730
| +2% | +$23.3K | 0.1% | 33 |
|
2017
Q1 | $1.02M | Sell |
31,304
-822
| -3% | -$26.7K | 0.1% | 31 |
|
2016
Q4 | $990K | Sell |
32,126
-177
| -0.5% | -$5.45K | 0.1% | 31 |
|
2016
Q3 | $1.04M | Sell |
32,303
-717
| -2% | -$23K | 0.11% | 31 |
|
2016
Q2 | $1.1M | Buy |
33,020
+581
| +2% | +$19.4K | 0.31% | 31 |
|
2016
Q1 | $912K | Buy |
32,439
+2,185
| +7% | +$61.4K | 0.1% | 39 |
|
2015
Q4 | $927K | Buy |
30,254
+2,607
| +9% | +$79.9K | 0.1% | 42 |
|
2015
Q3 | $824K | Sell |
27,647
-1,280
| -4% | -$38.2K | 0.09% | 42 |
|
2015
Q2 | $920K | Buy |
28,927
+466
| +2% | +$14.8K | 0.09% | 43 |
|
2015
Q1 | $939K | Buy |
28,461
+677
| +2% | +$22.3K | 0.09% | 42 |
|
2014
Q4 | $821K | Buy |
27,784
+463
| +2% | +$13.7K | 0.08% | 45 |
|
2014
Q3 | $766K | Buy |
27,321
+1,805
| +7% | +$50.6K | 0.08% | 47 |
|
2014
Q2 | $719K | Buy |
25,516
+179
| +0.7% | +$5.04K | 0.08% | 48 |
|
2014
Q1 | $772K | Hold |
25,337
| – | – | 0.08% | 46 |
|
2013
Q4 | $736K | Hold |
25,337
| – | – | 0.08% | 47 |
|
2013
Q3 | $691K | Hold |
25,337
| – | – | 0.08% | 47 |
|
2013
Q2 | $673K | Buy |
+25,337
| New | +$673K | 0.08% | 42 |
|